{"acute febrile neutrophilic dermatosis": 24.5, "acute myeloid leukaemia": 81.32, "acute myeloid leukaemia recurrent": 332.01, "agranulocytosis": 5.0, "anaemia": 9.63, "bacteraemia": 18.5, "blast cell count increased": 65.27, "bone marrow failure": 12.23, "bronchopulmonary aspergillosis": 15.28, "cardiac disorder": 2.17, "cellulitis": 2.09, "covid-19 pneumonia": 4.6, "cytopenia": 81.64, "disease progression": 3.14, "disease recurrence": 3.33, "drug resistance": 2.38, "febrile neutropenia": 72.1, "full blood count decreased": 5.22, "fungal infection": 6.32, "granulocyte count decreased": 48.25, "haematotoxicity": 68.47, "haemoglobin decreased": 2.49, "haemophagocytic lymphohistiocytosis": 7.22, "infection": 8.56, "leukocytosis": 3.65, "leukopenia": 3.2, "minimal residual disease": 180.57, "multiple organ dysfunction syndrome": 3.09, "myelodysplastic syndrome": 18.87, "myelosuppression": 38.71, "neutropenia": 21.03, "neutropenic sepsis": 54.4, "neutrophil count decreased": 11.1, "off label use": 4.97, "pancytopenia": 13.45, "platelet count decreased": 6.61, "pneumocystis jirovecii pneumonia": 6.98, "pneumonia": 4.69, "pneumonia fungal": 39.95, "pneumonitis": 5.26, "product use issue": 2.12, "respiratory failure": 2.16, "sepsis": 6.76, "septic shock": 9.15, "splenomegaly": 4.28, "staphylococcal sepsis": 16.42, "therapeutic product effect incomplete": 4.99, "thrombocytopenia": 13.06, "treatment failure": 3.38, "tumour lysis syndrome": 91.12, "unevaluable event": 2.81, "white blood cell count abnormal": 16.46, "white blood cell count decreased": 7.86}